Dabuzalgron
Dabuzalgron (Ro 115-1240) is an orally active and selective α-1A adrenergic receptor agonist for the treatment of urinary incontinence. Dabuzalgron protects against Doxorubicin-induced cardiotoxicity by preserving mitochondrial function[1].
Product Specifications
CAS Number
[219311-44-1]
Product Name Alternative
Ro 115-1240
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Adrenergic Receptor; Apoptosis
Type
Reference compound
Related Pathways
Apoptosis; GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Endocrinology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/dabuzalgron.html
Purity
98.72
Solubility
DMSO : 26 mg/mL (ultrasonic)
Smiles
CS(=O)(NC1=C(Cl)C=CC(OCC2=NCCN2)=C1C)=O
Molecular Formula
C12H16ClN3O3S
Molecular Weight
317.79
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
α adrenergic receptor
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse Muc6 shRNA (UAS) - Lentiviral mouse Muc6 shRNA (UAS, GFP) plasmid
Recombinant Salmonella typhimurium Motility protein A (motA), partial
Recombinant Salmonella typhimurium Motility protein A (motA), partial
Recombinant Salmonella typhimurium Motility protein A (motA), partial